Mirdot-S 50/5
  • Manufactured by - Intra life
  • Product type - Tab
  • Package Size - ( 10x10 )
Composition

Mirabegron 5 mg (as extended release form) + Solifenacin Succinate IP 5mg

Indication

Treatment of OAB symptoms of urge urinary incontinence, urgency, and urinary frequency

Enquiry Now Enquiry Now

MIRDOT-S 50/5 by Intralife Pvt. Ltd. combines Mirabegron 50 mg (Extended Release) and Solifenacin Succinate IP 5 mg, offering a dual-mechanism solution for the treatment of Overactive Bladder (OAB). It is clinically designed to manage urge urinary incontinence, urinary urgency, and frequent urination by relaxing the bladder muscles and increasing bladder storage capacity. MIRDOT-S 50/5 delivers long-lasting relief and improves patient quality of life through effective symptom control.

About shape
  • Relieves symptoms of Overactive Bladder (OAB)
  • Reduces urinary frequency and urgency
  • Controls urge urinary incontinence episodes
  • Enhances bladder storage capacity
  • Provides sustained symptom relief with once-daily dosing
  • Combines β3-agonist and antimuscarinic for superior efficacy
  • Improves day and nighttime bladder control
  • What is MIRDOT-S 50/5 used for?
    MIRDOT-S 50/5 is used for the treatment of Overactive Bladder (OAB) symptoms, including urge urinary incontinence, urgency, and frequent urination.
  • How do Mirabegron and Solifenacin work together?
    Mirabegron relaxes the bladder muscle by stimulating β3 receptors, while Solifenacin blocks muscarinic receptors to reduce bladder spasms. Together, they increase bladder capacity and reduce OAB symptoms more effectively than monotherapy.
  • Who can take MIRDOT-S 50/5?
    Adults diagnosed with OAB and experiencing bothersome urinary symptoms may be prescribed this combination by their healthcare provider.
  • How should MIRDOT-S 50/5 be taken?
    It should be taken once daily, preferably at the same time each day, with or without food, as advised by your doctor.
  • Are there any side effects?
    Some patients may experience dry mouth, constipation, headache, or increased blood pressure. These are usually mild and manageable.
  • How soon can I expect results with MIRDOT-S 50/5?
    Improvement may be noticed within the first 2 weeks, with full benefits typically observed within 4 to 8 weeks.
  • Is MIRDOT-S 50/5 safe for long-term use?
    Yes, it is safe and effective for chronic management of OAB symptoms under medical supervision.
  • Can it be used with other medications?
    Yes, but always consult your doctor before combining MIRDOT-S 50/5 with other treatments to avoid interactions.

Apply for PCD Pharma Franchise